Description
Composition- Cefuroxime 750 mg + Sulbactam 375 mg
Mode of Action- Combines bactericidal cephalosporin action with beta-lactamase inhibition for improved efficacy against resistant bacteria.
USPs- Enhanced resistant infection coverage; effective parenteral therapy; useful in moderate to severe infections.
Prescribing Specialties- Physician, Surgeon, Critical Care
